Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britta Siegmund

Showing results (1-10 of 327) with videos related to

Pageof 33
Sort By:
Journal of Crohn'S & Colitis|January 11, 2020
Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel DiseaseBritta Siegmund
Viszeralmedizin|November 12, 2015
Medical Therapy of Fibrostenotic Crohn's DiseaseBritta Siegmund
Biochemical Pharmacology|July 11, 2002
Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammationBritta Siegmund
The Lancet. Gastroenterology & Hepatology|April 12, 2017
Cytomegalovirus infection associated with inflammatory bowel diseaseBritta Siegmund
Zeitschrift Fur Gastroenterologie|September 17, 2019
Britta Siegmund
Digestive Diseases (Basel, Switzerland)|September 15, 2015
Management of Mild-to-Moderate Ulcerative ColitisBritta Siegmund
Immunity|March 30, 2010
Interleukin-18 in intestinal inflammation: friend and foe?Britta Siegmund
Lancet (London, England)|February 19, 2017
Is intensity the solution for FMT in ulcerative colitis?Britta Siegmund
Gut|November 10, 2011
Mesenteric fat in Crohn's disease: the hot spot of inflammation?Britta Siegmund
Journal of Crohn'S & Colitis|February 11, 2020
Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis?Britta Siegmund
Pageof 33

Showing results (1-10 of 327) with videos related to

Sort By:
Pageof 33
Journal of Crohn'S & Colitis|January 11, 2020
Janus Kinase inhibitors in the New Treatment Paradigms of Inflammatory Bowel DiseaseBritta Siegmund
Viszeralmedizin|November 12, 2015
Medical Therapy of Fibrostenotic Crohn's DiseaseBritta Siegmund
Biochemical Pharmacology|July 11, 2002
Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammationBritta Siegmund
The Lancet. Gastroenterology & Hepatology|April 12, 2017
Cytomegalovirus infection associated with inflammatory bowel diseaseBritta Siegmund
Zeitschrift Fur Gastroenterologie|September 17, 2019
Britta Siegmund
Digestive Diseases (Basel, Switzerland)|September 15, 2015
Management of Mild-to-Moderate Ulcerative ColitisBritta Siegmund
Immunity|March 30, 2010
Interleukin-18 in intestinal inflammation: friend and foe?Britta Siegmund
Lancet (London, England)|February 19, 2017
Is intensity the solution for FMT in ulcerative colitis?Britta Siegmund
Gut|November 10, 2011
Mesenteric fat in Crohn's disease: the hot spot of inflammation?Britta Siegmund
Journal of Crohn'S & Colitis|February 11, 2020
Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis?Britta Siegmund
Pageof 33